A novel lncRNA-mRNA-miRNA signature predicts recurrence and disease-free survival in cervical cancer

Cervical cancer (CC) patients have a poor prognosis due to the high recurrence rate. However, there are still no effective molecular signatures to predict the recurrence and survival rates for CC patients. Here, we aimed to identify a novel signature based on three types of RNAs [messenger RNA (mRNA...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Mengxiong, Tian, Xiaohui, Guo, Hongling, Xu, Xiaoyu, Liu, Yun, Hao, Xiulan, Fei, Hui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Associação Brasileira de Divulgação Científica 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8457683/
https://www.ncbi.nlm.nih.gov/pubmed/34550275
http://dx.doi.org/10.1590/1414-431X2021e11592

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8457683/
https://www.ncbi.nlm.nih.gov/pubmed/34550275
http://dx.doi.org/10.1590/1414-431X2021e11592

Ejemplares similares